Zadine 1mg Tablet

Expert advice for Zadine Tablet • You will be treated with drugs to prevent nausea and vomiting at the start of azacitidine treatment cycle. • You will be monitored with lab test to measure complete blood count before every treatment cycle to check development of anemia (low red blood count), neutropenia (abnormally low white blood cell count) or thrombocytopenia (abnormally low count of platelets in the blood). • Take extreme care to avoid pregnancy while on azacitidine therapy. • Inform your doctor if you have a history of congestive heart failure, unstable heart or lung disease. • Seek immediate medical attention if you experience difficulty in breathing, swelling of the lips, itching or rash. • Patients allergic to azacitidine or any of its ingredients should not be administered this. • Patients with advanced malignant liver cancer should not be given azacitidine. • Pregnant and breastfeeding women should also not be given azacitidine. • Children and adolescents below 18 years should not be given azacitidine.